Kenya Launches Lenacapavir in HIV Prevention Push - February 2026

Kenya is set to introduce Lenacapavir, a novel anti-HIV injection offering long-acting prevention and treatment. This development marks a significant advancement in HIV care accessibility. Kenya has launched Lenacapavir, a new long-acting injectable medication, marking a significant advancement in its efforts to combat new HIV infections. Meanwhile, Kenya's Minister of Health Aden Duale has refuted claims of Ksh 11 billion public funds being misappropriated within the SHA health insurance scheme.

More Videos

Lenacapavir rollout marks major step in Kenya’s fight against HIV

NTV Kenya (Youtube)

Waziri wa Afya Aden Duale aeleza Seneti kuhusu maendeleo ya SHA

Citizen TV (Youtube)